|
參與國際臨床試驗 大幅改變乳癌治療成績-黃俊升教授
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer |
NEJM全文 |
|
| 2 |
提升乳癌治療存活率新契機-盧彥伸教授
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer |
NEJM全文 |
|
| 3 |
領導亞州乳癌研究- 盧彥伸教授 林季宏主任
Is Breast Cancer in Asian and Asian American Women a Different Disease? |
JNCI全文 |
PDF檔 |
| 4 |
與Herve Friman教授共同榮登Nature期刊- 乳房醫學中心 陳偉武醫師
B cells are associated with survival and immunotherapy response in sarcoma |
Nature全文 |
PDF檔 |